Magtibay P M, Salmon Z, Keeney G L, Podratz K C
Department of Obstetrics and Gynecology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):396-401. doi: 10.1111/j.1525-1438.2006.00225.x.
Aggressive angiomyxoma (AA) was first described in 1983, and fewer than 150 cases have been reported in the world medical literature. These tumors are benign, locally infiltrative mesenchymal neoplasms with a predilection for the female pelvis and perineum and a tendency to recur. The size of AAs at presentation varies considerably; however, these tumors often achieve large dimensions before becoming clinically symptomatic. Surgical excision remains the mainstay of treatment, but whether clear, tumor-free surgical margins are necessary is controversial. We report a cohort of six patients treated surgically during the past 20 years for primary or recurrent AA. Treatment, surgical margin status, estrogen and progesterone receptor status, and outcomes are reviewed.
侵袭性血管黏液瘤(AA)于1983年首次被描述,世界医学文献报道的病例不足150例。这些肿瘤是良性的、具有局部浸润性的间叶性肿瘤,好发于女性盆腔和会阴,且有复发倾向。AA在初诊时大小差异很大;然而,这些肿瘤在出现临床症状之前往往已长得很大。手术切除仍然是主要的治疗方法,但切缘是否需要达到病理阴性尚存在争议。我们报告了过去20年间接受手术治疗的6例原发性或复发性AA患者。对治疗情况、手术切缘状态、雌激素和孕激素受体状态以及治疗结果进行了回顾。